
Is it safe to remove skin tags at home? Dermatologists weigh in.
Is it safe to remove skin tags at home? Dermatologists weigh in.
Show Caption
Hide Caption
Benefits of snail mucin: the latest TikTok trend
A surprising skincare trend of snail mucin has gone viral on TikTok, with insights from dermatologists on its benefits for hydration, anti-aging, and acne-combatting ingredients.
Skin tags are benign growths that can pop up in a few areas around the body, from your underarms, to the neck, to under the breasts. They're completely harmless, so it's fine to leave them alone if they don't bother you. But if you do want to remove them, there are options.
There are plenty of over-the-counter products marketed as skin tag removers, and quite a few natural remedies that might help too. But is it ever a good idea to attempt getting rid of skin tags at home? Some things should just be left to the professionals. Here's what dermatologists recommend.
Can I remove a skin tag on my own?
Technically, you can. In actuality, you probably shouldn't. Skin tags usually don't go away by themselves, and if you're tempted by the many products marketed as skin tag removers, it's important you understand the risks, says Dr. Jennifer Shastry, a Northwestern Medicine dermatologist.
If you attempt to remove the skin tag on your own, disrupting the skin barrier can leave you at a risk for infection, uncontrolled bleeding, and/or scarring. 'I have seen patients come in with chemical burns on their skin from attempting at-home skin tag removal,' Shastry says. 'So, I really would advise in-office removal, if that was desired.'
'I don't recommend any at-home treatments since I have seen terrible infections and scarring from people who have tried at home,' agrees Dr. Hayley Goldbach, a board-certified dermatologist and Mohs surgeon at Brown University. 'Many of the products marketed to remove skin tags are extremely harsh and can result in burns on the skin.'
The same logic applies to reported natural remedies for removing skin tags, such as applying tea tree oil, apple cider vinegar or garlic to the skin tag. 'They are unlikely to be completely effective and pose a significant risk of irritating the skin and causing rashes,' says Shastry.
Want strong, healthy hair? Dermatologist talks rice water's potential benefits
How to safely get rid of skin tags
If the skin tag is growing in size, or just generally becoming bothersome, dermatologists can perform a few in-office treatments to effectively and safely remove skin tags.
Depending on the size and location of the skin tag, you have a few options: snip removal, cryotherapy (a cold liquid nitrogen spray), cauterization (using heat energy to burn the skin tag), and shave removal (which is typically reserved for larger skin tags), says Shastry.
Skin tag removal often isn't covered by health insurance, says Goldbach. This is because it's usually considered to be a cosmetic treatment.
In case you missed: Warts can be stubborn to treat. Here's how to get rid of them.
What are skin tags a warning sign of?
Skin tags aren't typically dangerous or a warning sign of anything, says Goldbach. However, in rare cases, seeing a cluster of new skin tags could indicate there's change happening within your body (and potential underlying illness), in which case you should always consult your dermatologist, who may direct you to a healthcare provider.
Regardless, seeing any type of new, prominent growth on your skin always warrants a check-up with your dermatologist, especially if it's expanding in size, changing in color or painful or itchy, says Shastry. Sometimes, what you think might be a benign skin tag could actually be something more serious, like a melanoma.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
2 hours ago
- Yahoo
BayCare aligns with Northwestern and its renowned medical school
BayCare has signed a deal with Northwestern Medicine, a collaboration that officials say is a critical step in the nonprofit's bid to expand its academic health system Northwestern is a nationally renowned academic health system through its partnership with the Northwestern University Feinberg School of Medicine. Its deal with BayCare will provide more access to advanced medical treatments, expand clinical research and improve training and education for current and future physicians in the Tampa Bay region, officials said. 'This isn't the beginning, it's the next step in a journey we've been focused on for years,' BayCare President and CEO Stephanie Conners said in a news release. 'West Central Florida deserves more access to academic medicine and by entering into a strategic collaboration with Northwestern Medicine, we will accelerate our trajectory as an academic health system.' Academic health systems are designed to innovate and produce leading edge treatments by integrating clinical care with research and education. Locally, Tampa General Hospital bills itself as the region's only academic health system through its 50-year partnership with USF Health Morsani College of Medicine. BayCare already partners with the University of South Florida and Florida State University for sponsorship of residency programs in family and sports medicine. The collaboration with Northwestern will lead to new educational and training opportunities, making BayCare a more attractive option for physicians, residents, and students, officials said. Headquartered in Chicago, Northwestern operates 11 hospitals and more than 200 diagnostic and out-patient centers. Its flagship facility, Northwestern Memorial Hospital, has been named to the Best Hospitals Honor Roll by U.S. News and World Report for 13 consecutive years. The Feinberg School of Medicine received $742 million in research funding and awards in 2024, with 15 of its departments among the top 20 National Institute of Health award recipients. 'We are focused on collaborating with likeminded organizations that are driven by providing patients with greater access to world-class compassionate care, closer to where they live and work,' Northwestern President and CEO Howard Chrisman said in a statement. 'By collaborating with BayCare, we have the opportunity to train and educate the next generation of medical professionals and transform the clinical offerings to patients in West Central Florida.' BayCare, which operates 16 hospitals and more than a hundred clinics in the region, plans to house its academic and research operations in a 36-acre office park that it purchased for $145 million earlier this year. The site, adjacent to St. Joseph's, St. Joseph's Children's and St. Joseph's Women's hospitals in West Tampa, will be named the BayCare Academic Health and Research Corridor.


Newsweek
4 hours ago
- Newsweek
Stray Cat Steals Bread—Refuses To Give It Back in Hilarious Clip
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A former stray cat was caught stealing bread from his owners' kitchen, but once confronted, he refused to give it back, hanging on to it as if it was his most-prized possession. The hilarious theft was caught on camera and shared on TikTok. In the now-viral clip, shared in May, under the username @carlykfuller, the tuxedo cat, Corbin, from Denver, Colorado, can be seen holding the bread between his paws and his fangs, hanging on to it as his mom tries to take it away with tongs. "Side effects of taking in a stray cat: the demons come out," reads layover text in the clip, as the cat growls at his mom nonstop, managing to snatch a piece of bread while she takes it away form him. "Someone save me from this cat (he's actually a sweet boy until the demons come out)," the poster writes in the caption. While bread itself isn't necessarily toxic or dangerous to cats, it offers no nutritional values, and so they shouldn't really be eating it. Pet MD says that cats are "obligate carnivores," which means that they obtain most of their nutrients for their diet from meats and meat-based products. Because bread has no meat, it is essentially empty calories, which replace the proteins they need. Carbohydrates are also considered unhealthy for cats. Moreover, flavored breads are a major no for pets. Anything that includes sugar, spices, onions, or garlic is toxic to cats and must be avoided. Rough dough, even if plain, is also toxic. Other human foods that cats should never eat include chocolate, raw meat or eggs, nuts, grapes and raising, bones, yeast, milk, alcohol, and citrus among others. You can read the full list of foods that are toxic to felines here. Stock image: A cat on the grass plays with a baguette in its paws. Stock image: A cat on the grass plays with a baguette in its paws. getty images The video quickly went viral on social media and it has so far received over 472,000 views and more than 51,800 likes on the platform. One user, Christian S, commented: "Are you planning on eating that bread? If not why can't he just have it? Just saying." Shawnna Marie posted: "God forbid the cat wants a roll with dinner." Brooke.m added: "Our youngest cat came from the streets. He's a dumpster goblin. If I don't share bananas with him he'll murder my face. I literally just found my last banana on the floor in the kitchen …" Newsweek reached out to @carlykfuller for comment via TikTok comments. We could not verify the details of the case. Do you have funny and adorable videos or pictures of your pet you want to share? Send them to life@ with some details about your best friend, and they could appear in our Pet of the Week lineup.
Yahoo
6 hours ago
- Yahoo
Japan Facial Injectables Market Set to Reach Valuation of US$ 1,121.31 Million by 2033
Japan facial injectables market is set to thrives with growth in natural beauty trends, technological innovations, and urban demand. Despite regulatory and rural challenges, cultural shifts and economic factors fuel sustained growth potential. Chicago, June 09, 2025 (GLOBE NEWSWIRE) -- The Japan facial injectables market was valued at US$ 508.18 million in 2024 and is projected to reach US$ 1,121.31 million by 2033, growing at a CAGR of 9.52% during the forecast period 2025–2033. The Japan facial injectables market is experiencing a significant shift in consumer behavior with a growing preference for subtle, natural-looking enhancements over dramatic transformations. Younger demographics, particularly those in their 20s and 30s, are increasingly opting for preventative treatments like botulinum toxin to delay signs of aging. Social media platforms, such as Instagram and TikTok, play a pivotal role in shaping beauty ideals, with influencers promoting injectables as a routine part of self-care. Moreover, there is a noticeable rise in male consumers seeking facial injectables, driven by societal acceptance of male grooming and professional competitiveness. Request Sample Pages: This trend aligns with Japan's cultural emphasis on "kawaii" (cuteness) and polished aesthetics, pushing demand for products that enhance facial harmony. According to a 2024 survey by the Japan Aesthetic Medicine Association, over 60,000 men underwent injectable treatments last year, a sharp increase from previous years. Clinics in urban hubs like Tokyo and Osaka report a surge in demand for hyaluronic acid fillers for jawline contouring and under-eye rejuvenation. Additionally, the rise of hybrid work environments has reduced downtime concerns, encouraging more individuals to schedule quick procedures. As consumer awareness grows, brands are focusing on personalized treatment plans, ensuring safety and satisfaction in this evolving landscape of the Japan facial injectables market. Key Findings in Japan Facial Injectables Market Market Forecast (2033) US$1,121.31 million CAGR 9.52% By Product Type Botulinum Toxin/Botox (55.97%) By Age Group 35-50 Year (51.72%) By Gender Female (81.62%) By Clinic Type Dermatology Clinics (35.45%) By Application Wrinkle Reduction (39.97%) Top Drivers Japan's rapidly aging society seeking non-surgical facial rejuvenation solutions Growing acceptance of aesthetic procedures among younger Japanese professionals Advanced injection techniques developed specifically for Asian facial anatomy Top Trends Micro-dosing approaches gaining popularity for natural-looking results in Japan Preventative treatments starting earlier among Tokyo millennials and Gen-Z AI-powered facial analysis integration in Japanese aesthetic clinics nationwide Top Challenges Strict PMDA regulations limiting new product approvals and innovations High training requirements creating certified injector shortages across prefectures Price sensitivity among middle-income consumers limiting market expansion potential Technological Breakthroughs Redefining Aesthetic Treatments In the Japan facial injectables market, technological innovation is a key growth driver with new formulations and delivery methods enhancing treatment precision and outcomes. Advanced micro-droplet injection techniques are gaining popularity for their ability to deliver natural-looking results, particularly for delicate areas like under-eyes. Additionally, AI-powered consultation tools are transforming patient experiences, enabling simulations of post-treatment results. Major brands are also developing longer-lasting fillers with biocompatible materials tailored to Asian skin types. A report by the Japan Society of Aesthetic Surgery (JSAS) indicates that over 92,000 procedures utilized cutting-edge injection technologies last year, reflecting rapid market adoption. For instance, Galderma's latest hyaluronic acid filler, designed for thinner skin textures common in Japanese patients, saw over 30,000 applications in clinics nationwide. The rise of telemedicine platforms has further democratized access, with over 25,000 virtual consultations recorded for injectables in 2024. These advancements not only improve patient satisfaction but also attract tech-savvy millennials. Stakeholders can capitalize on this trend by investing in training for practitioners on novel technologies and partnering with tech firms for digital tools, positioning themselves as leaders in the innovation-driven Japan facial injectables market. Navigating Regulatory Hurdles in Aesthetic Innovations The Japan facial injectables market operates under a stringent regulatory environment, prioritizing patient safety while posing challenges for market entrants. The Pharmaceuticals and Medical Devices Agency (PMDA) mandates rigorous clinical trials for new products, often requiring Japan-specific data, which delays launches compared to regions like the EU. Advertising restrictions further complicate brand visibility, as clinics cannot make direct claims about treatment outcomes without substantiated evidence, impacting consumer outreach. Recent PMDA data from 2024 shows that approval times for new injectables have been reduced to an average of 10 months, down from 14 months in prior years, thanks to digital submission processes. However, only 1,200 certified dermatologists and plastic surgeons were licensed to perform advanced injectable treatments last year, limiting service availability. High-profile adverse reaction cases, such as a 2023 Tokyo incident involving off-label filler use affecting 50 patients, have tightened post-market surveillance. For stakeholders, navigating this landscape requires robust compliance strategies and investment in local clinical research. Building partnerships with certified practitioners and focusing on transparent communication can help overcome barriers in the Japan facial injectables market, ensuring trust and market penetration. Disparities in Urban and Rural Demand Patterns In the Japan facial injectables market, a significant urban-rural divide shapes demand dynamics as of 2024, driven by economic and accessibility factors. Urban hubs like Tokyo, Osaka, and Nagoya account for the majority of procedures, fueled by higher disposable incomes and exposure to global beauty trends via media. In contrast, rural regions lag due to fewer specialized clinics, lower awareness, and cultural hesitancy toward cosmetic enhancements, often viewing them as unnecessary or vain. According to a study by the Japan Cosmetic Industry Association (JCIA), Tokyo recorded over 78,000 injectable procedures last year, while rural prefectures like Shimane reported fewer than 2,000. Urban clinics also cater to convenience-driven clients, offering extended hours and premium services, with over 35,000 bookings for same-day treatments in Osaka. Rural consumers often travel to cities, facing additional costs, with travel-related expenses for treatments estimated at over US$500 per trip for 10,000 individuals in 2024. Stakeholders can address this gap by deploying mobile clinics or partnering with telemedicine platforms to offer virtual consultations. Targeted awareness campaigns highlighting safety and benefits could also boost rural adoption in the Japan facial injectables market, unlocking untapped potential. Competitive Dynamics Among Aesthetic Industry Players: Top 3 Players Control Nearly 60% Market Share The Japan facial injectables market is fiercely competitive as of 2024, with global and local players battling for dominance through innovation and brand trust. International leaders like Allergan (Botox) Galderma, and Medytox Inc leverage their extensive portfolios and global reputation, focusing on products suited for Asian facial structures. These 3 players collectively hold over 60% market share. On the other hand, domestic firms, such as Koken Co., are gaining ground with cost-effective fillers and culturally aligned marketing, appealing to price-sensitive consumers seeking trusted local brands. A 2024 report from the Japan Aesthetic Research Institute (JARI) notes that Allergan conducted over 55,000 Botox procedures last year, while Koken's fillers were used in 28,000 treatments, reflecting growing local traction. Strategic collaborations are key, with Merz partnering with 300 Tokyo clinics in 2024 for exclusive training, enhancing practitioner expertise. Local players counter with affordability, pricing treatments US$50-100 lower per session than global brands. Social media campaigns, involving over 200 influencers last year, have also become critical for brand visibility. For stakeholders, differentiating through niche offerings—like male-specific treatments or eco-friendly fillers—and building practitioner networks can secure a foothold in the dynamic Japan facial injectables market, balancing global standards with local relevance. Cultural Nuances Influencing Beauty Treatment Choices Cultural nuances profoundly influence the Japan facial injectables market as of 2024, shaping beauty perceptions and treatment choices. The Japanese ethos of 'mottainai' (avoiding waste) extends to maintaining a youthful appearance as a form of self-care and respect. Subtlety is prized, with consumers favoring injectables for minor enhancements like smoothing nasolabial folds over bold transformations, distinguishing Japan from markets like South Korea, where dramatic changes are often sought. A survey by the Japan Beauty Institute (JBI) found that 72,000 respondents preferred fillers for natural corrections, with over 40,000 treatments focusing on fine lines. J-pop and anime aesthetics drive younger demographics, with 25,000 procedures last year inspired by idol-like features. However, conservative attitudes among older generations persist, with only 15,000 clients aged 50+ opting for injectables due to stigma. Clinics in the Japan facial injectables market are reframing treatments as wellness solutions, hosting over 100 awareness seminars in 2024 to destigmatize aesthetics. Stakeholders can tap into this cultural landscape by emphasizing natural results and aligning with local beauty ideals. Tailored campaigns targeting younger and male demographics could further accelerate adoption in the market, blending tradition with modern aspirations. Economic Factors Steering Aesthetic Spending Trends Economic factors significantly impact the Japan facial injectables market as of 2024, with disposable income and cost pressures shaping consumer behavior. Japan's economy faces challenges like wage stagnation, limiting spending on non-essential services for middle- and lower-income groups. Urban professionals, however, view injectables as a career investment, prioritizing image in competitive job markets. Economic disparities thus create a segmented market where affluent areas drive the bulk of demand. A economic analysis by the Japan Finance Ministry highlights that import costs for foreign injectables rose in the facial injectables market due to a weaker yen, increasing treatment prices by US$20-30 per session in over 500 clinics. Despite this, demand in high-income Tokyo districts saw 58,000 procedures last year. Post-pandemic recovery has spurred discretionary spending, with over 30,000 young professionals using annual bonuses for aesthetics in 2024. Medical tourism, supported by government initiatives, also shows promise, with 5,000 international clients seeking treatments last year. Stakeholders can navigate economic constraints by offering tiered pricing or payment plans, ensuring accessibility. Leveraging tourism by marketing Japan as an aesthetic hub could further boost the market, aligning economic strategies with consumer realities. Need Custom Data? Let Us Know: Future Horizons for Aesthetic Treatment Innovations Looking forward, the Japan facial injectables market is poised for robust growth with emerging trends offering significant opportunities for stakeholders. Personalized treatments, aided by genetic profiling for customized fillers, are on the horizon, while male and senior demographics present untapped markets. Sustainability is also gaining traction, with biodegradable fillers attracting eco-conscious clients. The market is set to benefit from Japan's aging population, projected to drive demand for rejuvenation treatments. A forecast by the Japan Aesthetic Technology Forum predicts 45,000 users will adopt AR-based consultation tools by next year, enhancing treatment planning. Rural expansion via mobile clinics could reach 20,000 new clients annually, based on pilot programs in 2024. Global investment in Japanese aesthetic R&D is also rising, with over US$10 million allocated to local startups last year for innovative injectables. Challenges like regulatory delays and economic pressures remain, but strategic partnerships with tech firms and localized marketing can mitigate risks. For stakeholders, focusing on education, accessibility, and niche innovations—such as male-specific products—will be key to capitalizing on the evolving Japan facial injectables market, positioning Japan as a global leader in aesthetic advancements. Japan Facial Injectables Market Major Players: Galderma Allergan Aesthetics Medytox Inc. Hugel Inc. HA Derma VAIM Global Inc Other Prominent Players Key Segmentation: By Product Type Botulinum Toxin/Botox Derma Fillers Collagen Hyaluronic Acid (HA) Fat Injection Calcium Hydroxylapatite (CaHA) Poly-L-lactic Acid (PLLA) Others By Age Group 18-34 Years 35-50 Years 51+ Years By Gender Male Female By Clinic Type MedSpa Dermatology Clinics Hospitals Plastic Surgery Centers Others By Application Wrinkle Reduction Face Line Correction Lip Augmentation Face Lift Facial Contouring Acne Scar Treatment Lipoatrophy Treatment Others Need More Info? Ask Before You Buy: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data